Anebulo Pharmaceuticals, Inc. (ANEB) Tops Q1 EPS by 7c
Tweet
Share
E-mailGet Alerts ANEB Hot Sheet
Join SI Premium – FREE
Anebulo Pharmaceuticals, Inc. (NASDAQ: ANEB) reported Q1 EPS of ($0.05), $0.07 better than the analyst estimate of ($0.12).
For earnings history and earnings-related data on Anebulo Pharmaceuticals, Inc. (ANEB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
- Accenture becomes Seattle Seahawks' first global partner
- Jaguar Health files for full FDA approval of dog diarrhea drug
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
